Keyphrases
Proton Pump Inhibitors
100%
Competing Risk Analysis
100%
Major Adverse Renal Events
100%
Chronic Kidney Disease
45%
Decreased Glomerular Filtration Rate
27%
Proteinuria
27%
Diabetes
9%
Confidence Interval
9%
Biochemical Data
9%
Observational Cohort Study
9%
Secondary Care
9%
Hazard Ratio
9%
Multivariable
9%
Renal Function
9%
Creatinine
9%
End-stage Renal Disease
9%
Prospective Cohort Study
9%
Comorbidity
9%
Hypomagnesemia
9%
High Systolic Blood Pressure
9%
Renal Clinic
9%
Congestive Cardiac Failure
9%
Sociodemographic Data
9%
Tubulointerstitial Nephritis
9%
Cause-specific Hazard
9%
Adjustment Hazard
9%
Competing Risk Survival Analysis
9%
Medicine and Dentistry
Proton-Pump Inhibitor
100%
Chronic Kidney Disease
45%
Proteinuria
27%
Glomerular Filtration Rate
27%
Systolic Blood Pressure
9%
Diabetes
9%
Secondary Care
9%
Hazard Ratio
9%
Kidney Function
9%
Creatinine
9%
End Stage Renal Disease
9%
Prospective Cohort Study
9%
Cohort Study
9%
Survival Analysis
9%
Congestive Heart Failure
9%
Hypomagnesemia
9%
Interstitial Nephritis
9%